1-10 of 10
pantoprazole
Close
Sort by
Journal Articles

The First Case Report of Tazobactam Induced Thrombocytopenia

Minh-Tri H. Nguyen, MD, Pavneet Kaur, MD, Richard H. Aster, MD, Vidya Krishnan, MD MHS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4897.
https://doi.org/10.1182/blood-2019-126227
Published: 2019
Journal Articles

Population Pharmacokinetics of Ivosidenib (AG-120) in Patients with IDH1-Mutant Advanced Hematologic Malignancies

Kha Le, PhD, Russ Wada, PhD, David Dai, PhD, Bin Fan, PhD, Guowen Liu, PhD, Hua Liu, PhD, Eyal C. Attar, MD, Samuel V. Agresta, MD, Hua Yang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1394.
https://doi.org/10.1182/blood-2018-99-109863
Published: 2018
Journal Articles

The ABCC6 Transporter Plays a Significant Role in the Efflux of Nilotinib and Dasatinib, and May Contribute to Tyrosine Kinase Inhibitor Resistance

Laura N Eadie, PhD, Jarrad M Goyne, BMedSc (Hons), Timothy P. Hughes, MD FRACP, FRCPA, MBBS, FAAHMS, Deborah L White, PhD FFSc (RCPA)
Journal: Blood
Blood (2016) 128 (22): 4237.
https://doi.org/10.1182/blood.V128.22.4237.4237
Published: 2016
Journal Articles

Drug Metabolites Formed in Vivo Promote the Clearance of Human Platelets by Metabolite-Dependent Antibodies in NOD/SCID Mice

Daniel W. Bougie, PhD, Dhirendra Nayak, Richard H. Aster, MD
Journal: Blood
Blood (2012) 120 (21): 1083.
https://doi.org/10.1182/blood.V120.21.1083.1083
Published: 2012
Journal Articles

An Approach to the “Untransfusable” Patient

Gemma Louise Crighton, MD, Philip A Thompson, MD, Mary Gaskell, Marija Borosak, FRCPA, FRACP, MBBS, Anne C Dykes, MD, FRACP, FRCPA, Jennifer Condon, Scott McArdle, Merrole Faye Cole-Sinclair
Journal: Blood
Blood (2012) 120 (21): 4385.
https://doi.org/10.1182/blood.V120.21.4385.4385
Published: 2012
Journal Articles

ATP Dependent Efflux Transporters ABCB1 and ABCG2 Are Unlikely to Impact the Efficacy, or Mediate Resistance to the Tyrosine Kinase Inhibitor, Ponatinib

Deborah L. White, PhD. FFSc(RCPA), Liu Lu, BSc, Timothy P. Clackson, PhD, Verity A Saunders, BScHons, Timothy P Hughes, MD, MBBS
Journal: Blood
Blood (2011) 118 (21): 2745.
https://doi.org/10.1182/blood.V118.21.2745.2745
Published: 2011
Journal Articles

Proton Pump Inhibitors Augment Nilotinib and Dasatinib Mediated Bcr-Abl Kinase Inhibition

Devendra K Hiwase, MD, MBBS, FRACP, FRCPA, Laura Eadie, Verity Saunders, Timothy Hughes, MD, MBBS, Deborah L. White, PhD
Journal: Blood
Blood (2010) 116 (21): 3991.
https://doi.org/10.1182/blood.V116.21.3991.3991
Published: 2010
Journal Articles

The Effect of the Interaction between Proton Pump Inhibitors (PPI) and Tyrosine Kinase Inhibitors (Imatinib, Nilotinib and Dasatinib).

Piera La Cava, PhD, Annalisa Chiarenza, MD, Daniele Tibullo, PhD, Cesarina Giallongo, PhD, Alessandra Romano, MD, Fabio Stagno, MD, Giuseppe A. Palumbo, MD, Francesco Di Raimondo, MD
Journal: Blood
Blood (2007) 110 (11): 2957.
https://doi.org/10.1182/blood.V110.11.2957.2957
Published: 2007
Journal Articles

The Prevalence of Pantoprozole Associated Thrombocytopenia in a Community Hospital - A Retrospective Study.

Randi Katz, DO, Jason Bratcher, MD, Efrat Dotan, MD, Carrie Wasserman, MD, Michelene Liebman, MD, Sivakumar Reddy, MD, Amy Michael, PharmD, Aliasad Arastu, MD, Georgia Panagopoulos, PhD, Colette Spaccavento, MD
Journal: Blood
Blood (2005) 106 (11): 3980.
https://doi.org/10.1182/blood.V106.11.3980.3980
Published: 2005
Journal Articles

Short-Term Use of Phenobarbital in the Treatment of “Superwarfarin” Poisoning.

Cecilia V. Oliveri, MD, James R. Stubbs, MD, Tatyana Chernova, MD, Gary Ellis Carnahan, MD, PhD, Tara N. Evans, MD, Andrew Gammill, MD, Jonathan Siegel, MD
Journal: Blood
Blood (2004) 104 (11): 4024.
https://doi.org/10.1182/blood.V104.11.4024.4024
Published: 2004